Last Findings on Dual Inhibitors of Abl and Src Tyrosine-Kinases

E-ISSN： 1875-5607|7|2|191-201

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.7, Iss.2, 2007-02, pp. : 191-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual Inhibitors of Src and Abl Tyrosine Kinases

Drug Design Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 203-214

Bentham Science Publishers

Access to resources Recommend Favorite

Novel dual Src/Abl inhibitors for hematologic and solid malignancies

By Schenone Silvia Brullo Chiara Musumeci Francesca Botta Maurizio

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 931-945

Informa Healthcare

Access to resources Recommend Favorite

Targeting tyrosine-kinases in ovarian cancer

By Morotti Matteo Becker Christian M Menada Mario Valenzano Ferrero Simone

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1265-1279

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Tyrosine Kinases in the Treatment of Psoriasis

Current Pharmaceutical Design, Vol. 6, Iss. 9, 2000-06 ,pp. : 933-942

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 205-216

Bentham Science Publishers

Access to resources Recommend Favorite